Trial studying safety and effects for Violence Risk
Official title BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
ClinicalTrials.gov ID: NCT07417904
What this study is testing
- What it's testing
- This study is testing whether a new talk therapy helps people stay safe. It also looks at how well people use the treatment.
- Who it's for
- You may be able to join if you are a young adult with early psychosis.
- What's involved
- You would get your usual care first. Then you would join the new talk therapy sessions.
- Time commitment
- The study lasts for a set time with regular visits to the clinic.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 30
You may be able to join if
- Young adults aged 16-30 years
- Diagnosis of early psychosis
- Currently receiving outpatient care through an early psychosis clinic
- Psychiatrically stable and deemed appropriate for participation by a treating clinician
- Able and willing to provide informed consent
You likely can't join if
- Unable to provide informed consent
- Not fluent in English
- History of antisocial behavior, as assessed at baseline
- Immediate risk requiring a higher level of care
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.